MedPath

Dexamethasone

Dexamethasone Tablets USPPrasco, LLCRx only

Approved
Approval ID

16c59e9a-8e4f-4300-bbbb-bcc982c18fc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 19, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dexamethasone

PRODUCT DETAILS

NDC Product Code50090-6152
Application NumberANDA080399
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateMarch 31, 2023
Generic NameDexamethasone

INGREDIENTS (7)

DEXAMETHASONEActive
Quantity: 4 mg in 1 1
Code: 7S5I7G3JQL
Classification: ACTIB
MICROCRYSTALLINE CELLULOSE 102Inactive
Code: PNR0YF693Y
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dexamethasone - FDA Drug Approval Details